Washington DC… The HIV+Hepatitis Policy Institute applauds the release of the HIV National Strategic Plan: A Roadmap to End the Epidemic by the U.S. Department of Health and Human Services…
Trump Administration fails to protect patient affordability of medications: Biden Administration must step in to improve affordability
Washington DC… Today, the Trump administration rushed out the partial release of the rules that govern how private health plans must operate in 2022 and in doing so…
HIV+Hep welcomes first Hepatitis strategic plan that calls for elimination
Washington DC… The HIV+Hepatitis Policy Institute applauds the U.S. Department of Health and Human Services (HHS) for today’s release of Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021 – 2025)…
Congress proposes increases for ending HIV: Funding for Hepatitis programs falls short
Washington DC… House and Senate appropriators have proposed an increase of approximately $137 million for ramping up efforts to end HIV in the United States in the FY2021 omnibus spending bill released today…
Trump Administration temporarily backs off from proposal that would endanger patient copay assistance
Washington DC… In a victory for patients’ ability to afford prescription drugs, the Trump administration has delayed for two years implementation of a provision included in a proposed…